Clinical Trial Update: Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq

View source ↗

Summary

The trial evaluating immune tolerance induction in Hemophilia A patients using Wilate or Nuwiq has been terminated, with results posted on 2024-08-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Nuwiq (recombinant factor VIII concentrate)
• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Hemophilia A | Status: TERMINATED | Results posted: 2024-08-09